Cargando…
Insights on therapeutic potential of clemastine in neurological disorders
Clemastine, a Food and Drug Administration (FDA)-approved compound, is recognized as a first-generation, widely available antihistamine that reduces histamine-induced symptoms. Evidence has confirmed that clemastine can transport across the blood–brain barrier and act on specific neurons and neurogl...
Autores principales: | Jiang, Sufang, Wang, Xueji, Cao, Tianyu, Kang, Rongtian, Huang, Lining |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568021/ https://www.ncbi.nlm.nih.gov/pubmed/37840769 http://dx.doi.org/10.3389/fnmol.2023.1279985 |
Ejemplares similares
-
Glymphatic system: an emerging therapeutic approach for neurological disorders
por: Gao, Ying, et al.
Publicado: (2023) -
Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders
por: Tian, Zhen, et al.
Publicado: (2022) -
Clemastine Alleviates Depressive-Like Behavior Through Reversing the Imbalance of Microglia-Related Pro-inflammatory State in Mouse Hippocampus
por: Su, Wen-Jun, et al.
Publicado: (2018) -
Clemastine Induces an Impairment in Developmental Myelination
por: Palma, Ana, et al.
Publicado: (2022) -
Repurposing Clemastine to Target Glioblastoma Cell Stemness
por: Sun, Michael A., et al.
Publicado: (2023)